Literature DB >> 28233395

A latent class model for competing risks.

M Rowley1,2, H Garmo3, M Van Hemelrijck3, W Wulaningsih3, B Grundmark4,5, B Zethelius5,6, N Hammar7,8, G Walldius9, M Inoue10, L Holmberg3, A C C Coolen1.   

Abstract

Survival data analysis becomes complex when the proportional hazards assumption is violated at population level or when crude hazard rates are no longer estimators of marginal ones. We develop a Bayesian survival analysis method to deal with these situations, on the basis of assuming that the complexities are induced by latent cohort or disease heterogeneity that is not captured by covariates and that proportional hazards hold at the level of individuals. This leads to a description from which risk-specific marginal hazard rates and survival functions are fully accessible, 'decontaminated' of the effects of informative censoring, and which includes Cox, random effects and latent class models as special cases. Simulated data confirm that our approach can map a cohort's substructure and remove heterogeneity-induced informative censoring effects. Application to data from the Uppsala Longitudinal Study of Adult Men cohort leads to plausible alternative explanations for previous counter-intuitive inferences on prostate cancer. The importance of managing cardiovascular disease as a comorbidity in women diagnosed with breast cancer is suggested on application to data from the Swedish Apolipoprotein Mortality Risk Study.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  competing risks; heterogeneity; informative censoring; survival analysis

Mesh:

Substances:

Year:  2017        PMID: 28233395     DOI: 10.1002/sim.7246

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Inference on latent factor models for informative censoring.

Authors:  Francesco Ungolo; Edwin R van den Heuvel
Journal:  Stat Methods Med Res       Date:  2022-01-25       Impact factor: 3.021

2.  HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial.

Authors:  Paul R Barber; Gregory Weitsman; Katherine Lawler; James E Barrett; Mark Rowley; Manuel Rodriguez-Justo; David Fisher; Fangfei Gao; Iain D C Tullis; Jinhai Deng; Louise Brown; Richard Kaplan; Daniel Hochhauser; Richard Adams; Timothy S Maughan; Borivoj Vojnovic; Anthony C C Coolen; Tony Ng
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

3.  Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus.

Authors:  Christel Häggström; Mieke Van Hemelrijck; Hans Garmo; David Robinson; Pär Stattin; Mark Rowley; Anthony C C Coolen; Lars Holmberg
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.